The largest database of trusted experimental protocols

Sas enterprise guide software version 6

Manufactured by SAS Institute
Sourced in United States

SAS Enterprise Guide Software version 6.1 is a graphical user interface (GUI) that provides a point-and-click environment for accessing the SAS System. It allows users to access SAS, build and run programs, and view results without having to learn the SAS programming language.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using sas enterprise guide software version 6

1

COVID-19 Risk Factors in Hypertension

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the general characteristics of the analysis data, the subjects of hypertension and non-hypertension were classified, and the mean and median values for the continuous variable and the frequency and ratio for the categorical variable were indicated. In hypertensive patients, a chi-square test was performed for each independent variable, frequency and ratio, which are expected to affect COVID-19 infection risk. In addition, multivariate logistic regression was performed to confirm the influence of the independent variable considering the interaction of each variable. The severity of COVID-19 patients was divided into five stages, and the independent variables, frequencies and ratios expected to affect clinical severity were analyzed by performing a chi-square test. Multivariate analysis was performed using logistic regression to evaluate the association between selected clinical characteristics and a likelihood of a positive test for COVID-19/COVID-19 severity. SAS Enterprise Guide Software version 6.1 (SAS Institute Inc., Cary, NC) was used for these analyses, and a P value of less than .05 was considered statistically significant.
+ Open protocol
+ Expand
2

Demographic and Medication Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Demographic characteristics, comorbidities and comedication profiles were reported cross-sectionally in 2018. The descriptive analysis of patient characteristics and health outcomes was summarized using means and standard deviation (SD) for continuous variables and using counts and percentages for ordinal and nominal variables. The chi-square test was used to compare between groups and each DDI across the three DAA regimens. All data analyses were performed using SAS® Enterprise Guide software version 6.1 (SAS Institute Inc., Cary, NC, USA). Statistical significance was assessed at p < 0.05.
+ Open protocol
+ Expand
3

Risk of Tuberculosis in IBD Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data are presented as mean ± standard deviation (SD) for continuous variables or as numbers and percentages for categorical variables. Univariate Cox's proportional-hazards regression model was used to assess hazard ratios (HR) and 95% confidence intervals (CI) of TB occurrence between each treatment and control group. To achieve a balance of patient's age, sex, and disease duration between groups in IBD patients, a one-to-one greedy matching (one case per one control) with the nearest-neighbor algorithm was performed. The same matching procedure was conducted within CD and UC patients. The incidence of TB and its 95% CI for each treatment group was calculated per 10,000 person-years. The median days on medication before TB was defined as the median value of the medication period from the initial to the onset of TB in each treatment group. A stratified Cox proportional-hazards regression analysis for the matched-pair data were used to evaluate the relative hazard of events in the treatment group compared to the control group. Cumulative incidence for the study outcome was estimated using the Kaplan-Meier method. A two-sided P-value < 0.05 was considered to be statistically significant. All statistical analyses were performed using the SAS Enterprise Guide software version 6.1 (SAS Institute Inc., Cary, NC, USA).
+ Open protocol
+ Expand
4

Neonatal Morbidity Trends and Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analysis was undertaken using SAS® Enterprise Guide® software, Version 6.1 (SAS Institute Inc., Cary, NC, USA).
The incidence of neonatal morbidity overall and for each of the diagnosis or procedure components was calculated for the entire cohort and for the first and last year of the study period (2002 and 2014). Cochran-Armitage trend tests were used to assess the change in incidence over time for each component, with significance set at P < 0.01. The influence of each individual component on the NAOI was determined by removing it from the indicator and calculating the incidence decrease. Gestational age-specific rates of neonatal morbidity were also calculated as an assessment of validity. Infants with missing hospital records were retained for these analyses, as they made up only a small proportion of the cohort (n = 8,676; 0.7%) and neonatal morbidity could still be identified by birth data indicator components alone. For records with no missing data, the odds of neonatal morbidity was reported for select maternal and infant characteristics. For infants discharged home, rates of hospital readmission (any and overnight) and death within the first year of life were reported.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!